Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

It's flu season right now, and the U.S. is in the midst of a wave that's straining hospitals. But not all influenza is the ...

The Illinois Department of Public Health (IDPH) reported respiratory illnesses have increased and the illness level is now at ...

A Tennessee federal court has upheld a jury’s verdict in favor of former BlueCross BlueShield of Tennessee (BCBST) employee ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...

The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.

Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...

The vaccines’ effect on inflammation-promoting cells might help to explain why the jabs protect against severe disease.

It was filed on behalf of 10 former employees by the nonprofit Silent Majority Foundation, based in Pasco and directed by ...

PROVIDENCE, R.I. (AP) — A letter submitted to the U.S. Senate that states it was sent by physicians in support of Robert F. Kennedy Jr.’s nomination as secretary of Health and Human Services includes ...

The COVAIL trial reveals that neutralizing antibody titers correlate with COVID-19 risk reduction after mRNA boosters. Learn how this impacts vaccine strategies against emerging variants.